Current status of low molecular weight heparins in clinical practice.
Vidhya
M R
MR
Department of Cardiology, Apollo Hospitals, Chennai.
Sathyamurthy
I
I
D003327:Coronary Disease / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight